Evolving concepts in the primary prevention of cardiovascular disease: aspirin then and now

被引：0
作者：
Hennekens, Charles H. [1 ]
Bjorkman, David J. [1 ]
机构：
[1] Florida Atlantic Univ, Charles E Schmidt Coll Med, 777 Glades Rd,Bldg 71,Suites 210 & 337, Boca Raton, FL 33431 USA
来源：
FUTURE CARDIOLOGY | 2014年 / 10卷 / 05期
基金：
加拿大健康研究院;
关键词：
aspirin; primary prevention; cardiovascular disease;
D O I：
10.2217/FCA.14.49
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：583 / 586
页数：4
相关论文
共 19 条
  • [1] LOW-DOSE ASPIRIN FOR MIGRAINE PROPHYLAXIS
    BURING, JE
    PETO, R
    HENNEKENS, CH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (13): : 1711 - 1713
  • [2] Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
  • [3] Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment
    Cryer, Byron
    Mahaffey, Kenneth W.
    [J]. JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2014, 7 : 137 - 146
  • [4] Elwood P. C., 2012, Clinical Investigation, V2, P1177, DOI 10.4155/cli.12.124
  • [5] Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease - Randomized and observational comparisons of secondary prevention trials and their meta-analyses
    Hennekens, CH
    Sacks, FM
    Tonkin, A
    Jukema, JW
    Byington, RP
    Pitt, B
    Berry, DA
    Berry, SM
    Ford, NF
    Walker, AJ
    Natarajan, K
    Sheng-Lin, C
    Fiedorek, FT
    Belder, R
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (01) : 40 - 44
  • [6] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY
    HENNEKENS, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) : 129 - 135
  • [7] Hennekens CH, 2006, J CARDIOVASC PHARM T, V11, P1
  • [8] Hennekens CH, 1988, N ENGL J MED, V318, P262
  • [9] Hennekens CH, 2013, CLIN INVESTIGATOR, V3, P447
  • [10] PREVENTION Aspirin in primary prevention needs individual judgements
    Hennekens, Charles H.
    DeMets, David L.
    [J]. NATURE REVIEWS CARDIOLOGY, 2014, 11 (08) : 438 - 440
12